About

Biosolyx Co., Ltd. is a research-oriented company that creates value for our customers

Pipeline

Section Candidate
Selection
Development
Progress
Commercialization      
Gene
Delivery
For
Experimental
Use
For
Production
Section Candidate
Selection
Non-clinical Animal
Clinic
Clinical
Trial Phase 1
Clinical
Trial Phase 2
Clinical
Trial Phase 3
Gene
Delivery
For
animals
For
human body
Drug
Delivery
Anti-cancer
Delivery
Section
Gene
Transporter
For
Experimental
Use
  • Development and production of transfection reagents with high gene delivery efficiency and low cytotoxicity, such as pDNA, siRNA, and mRNA
  • Validation in various cells
  • Custom Reagents available
For
Production
  • Development of transfection reagent required for virus, protein, and antibody production
  • Development of industrial GMP level reagents
  • Custom reagents available
For
animals
  • Development of LNP (lipid nanoparticle) materials for DNA and mRNA vaccines
  • Animal vaccine development MOU signed
For
human body
  • Development of LNP substances for mRNA vaccines
  • Conducting projects with K-medihub with the goal of pre-clinical trials
Drug
Delivery
Anti-cancer
Delivery